Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer.
Koshiro N, Nakajima K, Oyama M, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators.
Koshiro N, et al. Among authors: kaneko g.
Int J Urol. 2022 Dec;29(12):1477-1487. doi: 10.1111/iju.15022. Epub 2022 Sep 7.
Int J Urol. 2022.
PMID: 36070138